Phibro Animal Health (NASDAQ: PAHC)
Q4 2022 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | (EXPECTED)2022-08-24 | ||||||
REV |
Q3 2022 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | 0.350 | 0.330 | -0.0200 | ||||
REV | 226.260M | 239.600M | 13.340M |
Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
---|
You can purchase shares of Phibro Animal Health (NASDAQ: PAHC) through any online brokerage.
Other companies in Phibro Animal Health’s space includes: Atea Pharmaceuticals (NASDAQ:AVIR), Theravance Biopharma (NASDAQ:TBPH), GH Research (NASDAQ:GHRS), CinCor Pharma (NASDAQ:CINC) and Sundial Growers (NASDAQ:SNDL).
The latest price target for Phibro Animal Health (NASDAQ: PAHC) was reported by Barclays on Monday, January 10, 2022. The analyst firm set a price target for 23.00 expecting PAHC to rise to within 12 months (a possible 15.87% upside). 3 analyst firms have reported ratings in the last year.
The stock price for Phibro Animal Health (NASDAQ: PAHC) is $19.85 last updated Today at July 5, 2022, 2:36 PM UTC.
A quarterly cash dividend of $0.12 per share of Class A Common Stock. The quarterly cash dividend was payable on June 22, 2022 to stockholders of record on May 31, 2022.
Phibro Animal Health’s Q4 earnings are confirmed for Wednesday, August 24, 2022.
There is no upcoming split for Phibro Animal Health.
Phibro Animal Health is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.